510(k) Report

FDA product code · Gastroenterology and urology

Agent, Bulking, Injectable For Gastro-Urology Use

LNMClass IIIPMA required9 decisions since 19932 recalls

9 FDA decisions since 1993. 2 recalls name this code, 0 of them Class I.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026 Download the data (CSV)

FIG. A — Illustration, gastroenterology and urology panel

Twenty years of LNM at a glance: how often FDA decides these devices, how long 510(k) reviews take, how often they are recalled, and how many adverse event reports name the code.

FDA decisions per year · LNM

7in 2025

2007: 192008: 262009: 182010: 92011: 102012: 122013: 122014: 162015: 72016: 32017: 72018: 72019: 102020: 232021: 52022: 132023: 142024: 82025: 72026 (partial year): 7
2007high 26 (2008) · low 3 (2016)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · LNM

Too few LNM 510(k)s in any year since 2007 to give a median.

Recalls per year · LNM

1in 2020

2020: 1
2007high 1 (2020) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · LNM

59in 2025

2007: 452008: 252009: 252010: 382011: 552012: 602013: 622014: 522015: 592016: 722017: 862018: 362019: 82020: 72021: 112022: 182023: 162024: 652025: 59
2007high 86 (2017) · low 7 (2020)2025

MAUDE reports naming product code LNM, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200719—045
200826—025
200918—025
20109—038
201110—055
201212—060
201312—062
201416—052
20157—059
20163—072
20177—086
20187—036
201910—08
202023—17
20215—011
202213—018
202314—016
20248—065
20257—059
20267—0—
FIG. 1 — LNM by year, 2007–2026Sources: FDA decision databases, recall and enforcement reports, MAUDE · Data through Oct 25, 2026

Planning a device in LNM? A 510(k) Report ranks candidate predicates in this code by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report